Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients

计划入组 24 人 · 首次发布于 2011 年 2 月 10 日

Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection

计划入组 10 人 · 首次发布于 2012 年 3 月 22 日

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

计划入组 6 人 · 首次发布于 2004 年 8 月 6 日

DCM-205

MWAC-0001911

MBX-406

University of Limerick

Ireland

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Assembly Bio Initiates Phase 1a Trial of First-in-Class Oral HDV Entry Inhibitor ABI-6250

Novel Small Molecule MWAC-3634 Stabilizes Ebola Entry Protein, Blocks Infection at 0.65 nM

FDA Grants First-Ever Approval for Hepatitis Delta Treatment with Gilead's Hepcludex